

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 9.50310169 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 9.50310169 |
| 3 | negative T cell selection (GO:0043383) | 8.66686503 |
| 4 | regulation of isotype switching to IgG isotypes (GO:0048302) | 8.51706424 |
| 5 | negative thymic T cell selection (GO:0045060) | 8.25865825 |
| 6 | positive T cell selection (GO:0043368) | 7.99113800 |
| 7 | positive thymic T cell selection (GO:0045059) | 7.81357240 |
| 8 | thymic T cell selection (GO:0045061) | 7.24740099 |
| 9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.07711515 |
| 10 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.98417398 |
| 11 | cellular response to interleukin-15 (GO:0071350) | 6.96117453 |
| 12 | T cell selection (GO:0045058) | 6.88410585 |
| 13 | interferon-gamma production (GO:0032609) | 6.66301106 |
| 14 | response to interleukin-15 (GO:0070672) | 6.61957047 |
| 15 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.28067952 |
| 16 | T cell migration (GO:0072678) | 6.11718575 |
| 17 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.77250445 |
| 18 | * T cell receptor signaling pathway (GO:0050852) | 5.62657795 |
| 19 | activated T cell proliferation (GO:0050798) | 5.40789493 |
| 20 | negative regulation of T cell mediated immunity (GO:0002710) | 5.33955255 |
| 21 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 5.28883913 |
| 22 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 5.28883913 |
| 23 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.27294507 |
| 24 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.27294507 |
| 25 | T cell costimulation (GO:0031295) | 5.27067662 |
| 26 | regulation of gamma-delta T cell activation (GO:0046643) | 5.22902940 |
| 27 | lymphocyte costimulation (GO:0031294) | 5.22039391 |
| 28 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.20030378 |
| 29 | regulation of natural killer cell mediated immunity (GO:0002715) | 5.13676528 |
| 30 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 5.13676528 |
| 31 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 5.11214922 |
| 32 | leukocyte aggregation (GO:0070486) | 5.01857426 |
| 33 | positive regulation of isotype switching (GO:0045830) | 4.98149337 |
| 34 | regulation of T cell tolerance induction (GO:0002664) | 4.78681543 |
| 35 | * antigen receptor-mediated signaling pathway (GO:0050851) | 4.69568892 |
| 36 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.68249846 |
| 37 | regulation of isotype switching (GO:0045191) | 4.56410457 |
| 38 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.55802924 |
| 39 | positive regulation of DNA recombination (GO:0045911) | 4.52238310 |
| 40 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.48863787 |
| 41 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.46588905 |
| 42 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.46031807 |
| 43 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.42898408 |
| 44 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.35974180 |
| 45 | positive regulation of B cell mediated immunity (GO:0002714) | 4.35440553 |
| 46 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 4.35440553 |
| 47 | regulation of regulatory T cell differentiation (GO:0045589) | 4.24112682 |
| 48 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 4.23966008 |
| 49 | regulation of immunoglobulin mediated immune response (GO:0002889) | 4.16590691 |
| 50 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.13211011 |
| 51 | positive regulation of granulocyte differentiation (GO:0030854) | 4.09718233 |
| 52 | tolerance induction (GO:0002507) | 4.09608223 |
| 53 | detection of bacterium (GO:0016045) | 4.02593259 |
| 54 | regulation of cell killing (GO:0031341) | 4.02021559 |
| 55 | regulation of B cell mediated immunity (GO:0002712) | 3.99949995 |
| 56 | positive regulation of immunoglobulin production (GO:0002639) | 3.96078035 |
| 57 | positive regulation of cell killing (GO:0031343) | 3.94258226 |
| 58 | signal complex assembly (GO:0007172) | 3.91694902 |
| 59 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.91653754 |
| 60 | positive regulation of tolerance induction (GO:0002645) | 3.87073254 |
| 61 | regulation of B cell differentiation (GO:0045577) | 3.82486330 |
| 62 | detection of other organism (GO:0098543) | 3.82023115 |
| 63 | lymphocyte migration (GO:0072676) | 3.80836948 |
| 64 | T cell differentiation (GO:0030217) | 3.79974504 |
| 65 | positive regulation of B cell differentiation (GO:0045579) | 3.77557377 |
| 66 | mast cell activation (GO:0045576) | 3.75315188 |
| 67 | regulation of immunoglobulin production (GO:0002637) | 3.74832313 |
| 68 | alpha-beta T cell differentiation (GO:0046632) | 3.71156880 |
| 69 | negative regulation of phagocytosis (GO:0050765) | 3.68269487 |
| 70 | regulation of response to tumor cell (GO:0002834) | 3.67983249 |
| 71 | positive regulation of response to tumor cell (GO:0002836) | 3.67983249 |
| 72 | positive regulation of immune response to tumor cell (GO:0002839) | 3.67983249 |
| 73 | regulation of immune response to tumor cell (GO:0002837) | 3.67983249 |
| 74 | sequestering of actin monomers (GO:0042989) | 3.64832501 |
| 75 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.63516582 |
| 76 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.62191498 |
| 77 | NIK/NF-kappaB signaling (GO:0038061) | 3.62147565 |
| 78 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.59760150 |
| 79 | alpha-beta T cell activation (GO:0046631) | 3.59181386 |
| 80 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.59002930 |
| 81 | regulation of response to interferon-gamma (GO:0060330) | 3.56432048 |
| 82 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.51309165 |
| 83 | Peyers patch development (GO:0048541) | 3.51205113 |
| 84 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.51205113 |
| 85 | positive regulation by symbiont of host defense response (GO:0052509) | 3.46364221 |
| 86 | modulation by symbiont of host defense response (GO:0052031) | 3.46364221 |
| 87 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.46364221 |
| 88 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.46364221 |
| 89 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.46364221 |
| 90 | modulation by symbiont of host immune response (GO:0052553) | 3.46364221 |
| 91 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.45738791 |
| 92 | regulation of defense response to virus by virus (GO:0050690) | 3.43578973 |
| 93 | cellular response to type I interferon (GO:0071357) | 3.42840131 |
| 94 | type I interferon signaling pathway (GO:0060337) | 3.42840131 |
| 95 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.42480569 |
| 96 | immunoglobulin mediated immune response (GO:0016064) | 3.42424474 |
| 97 | response to type I interferon (GO:0034340) | 3.41448822 |
| 98 | positive regulation of interleukin-2 production (GO:0032743) | 3.41196737 |
| 99 | T cell differentiation involved in immune response (GO:0002292) | 3.40332434 |
| 100 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.40332434 |
| 101 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.40332434 |
| 102 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.37710351 |
| 103 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.34301028 |
| 104 | T cell activation (GO:0042110) | 3.34110287 |
| 105 | positive regulation of humoral immune response (GO:0002922) | 3.31897063 |
| 106 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.29752338 |
| 107 | regulation of tolerance induction (GO:0002643) | 3.27684172 |
| 108 | regulation of lymphocyte mediated immunity (GO:0002706) | 3.26268717 |
| 109 | respiratory burst (GO:0045730) | 3.22474419 |
| 110 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.21907682 |
| 111 | heterotypic cell-cell adhesion (GO:0034113) | 3.20882923 |
| 112 | * immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.17506379 |
| 113 | natural killer cell activation (GO:0030101) | 3.17063496 |
| 114 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.16713472 |
| 115 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.16045487 |
| 116 | negative regulation of adaptive immune response (GO:0002820) | 3.14413522 |
| 117 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.13269433 |
| 118 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.12364994 |
| 119 | neutrophil activation involved in immune response (GO:0002283) | 3.09947411 |
| 120 | positive regulation of interleukin-4 production (GO:0032753) | 3.07578718 |
| 121 | * B cell receptor signaling pathway (GO:0050853) | 3.05715462 |
| 122 | positive regulation of T cell activation (GO:0050870) | 3.04839417 |
| 123 | T cell homeostasis (GO:0043029) | 3.03734213 |
| 124 | leukocyte cell-cell adhesion (GO:0007159) | 3.02784460 |
| 125 | cellular defense response (GO:0006968) | 3.00276984 |
| 126 | T-helper cell differentiation (GO:0042093) | 2.99088186 |
| 127 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.99088186 |
| 128 | mast cell activation involved in immune response (GO:0002279) | 2.98085866 |
| 129 | mast cell degranulation (GO:0043303) | 2.98085866 |
| 130 | negative regulation of innate immune response (GO:0045824) | 2.93049891 |
| 131 | detection of external biotic stimulus (GO:0098581) | 2.86586434 |
| 132 | actin nucleation (GO:0045010) | 2.85230337 |
| 133 | neutrophil activation (GO:0042119) | 2.85104688 |
| 134 | negative regulation of T cell apoptotic process (GO:0070233) | 2.80475133 |
| 135 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.79203597 |
| 136 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.78890355 |
| 137 | regulation of alpha-beta T cell activation (GO:0046634) | 2.78740422 |
| 138 | macrophage activation involved in immune response (GO:0002281) | 2.78109326 |
| 139 | mature B cell differentiation involved in immune response (GO:0002313) | 2.77611236 |
| 140 | regulation of interleukin-4 production (GO:0032673) | 2.76737561 |
| 141 | dendritic cell chemotaxis (GO:0002407) | 2.74398552 |
| 142 | lymphocyte homeostasis (GO:0002260) | 2.74228689 |
| 143 | regulation of T cell mediated immunity (GO:0002709) | 2.73052374 |
| 144 | regulation of granulocyte differentiation (GO:0030852) | 2.69423031 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 8.89874930 |
| 2 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 7.59402385 |
| 3 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 4.16372442 |
| 4 | RUNX_20019798_ChIP-Seq_JUKART_Human | 4.13539501 |
| 5 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 4.02645128 |
| 6 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.82632525 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.66463714 |
| 8 | * MYB_26560356_Chip-Seq_TH2_Human | 3.25604057 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.22220687 |
| 10 | * MYC_22102868_ChIP-Seq_BL_Human | 3.08159108 |
| 11 | MAF_26560356_Chip-Seq_TH1_Human | 3.01361837 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.80437906 |
| 13 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.78583754 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.74170985 |
| 15 | MYB_26560356_Chip-Seq_TH1_Human | 2.72594920 |
| 16 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.72489502 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.44456363 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.42713676 |
| 19 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.32416901 |
| 20 | MAF_26560356_Chip-Seq_TH2_Human | 2.30040618 |
| 21 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.20607481 |
| 22 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.15404738 |
| 23 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.05923598 |
| 24 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.98975610 |
| 25 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.96164701 |
| 26 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.95129701 |
| 27 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.92628000 |
| 28 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.89574733 |
| 29 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.88757100 |
| 30 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.86041983 |
| 31 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84710697 |
| 32 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.81693927 |
| 33 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.77149953 |
| 34 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.75042428 |
| 35 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.72712475 |
| 36 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.69101663 |
| 37 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.60064031 |
| 38 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.59302543 |
| 39 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.58781859 |
| 40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58490090 |
| 41 | P68_20966046_ChIP-Seq_HELA_Human | 1.54927258 |
| 42 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.54400973 |
| 43 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.52718831 |
| 44 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.49491747 |
| 45 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.47314770 |
| 46 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.41227132 |
| 47 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.34529956 |
| 48 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.29605949 |
| 49 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.27820238 |
| 50 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25311109 |
| 51 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.25249606 |
| 52 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.23995186 |
| 53 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.23090152 |
| 54 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.23012456 |
| 55 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.22143823 |
| 56 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21659166 |
| 57 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.21261050 |
| 58 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.21077378 |
| 59 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.20617444 |
| 60 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.19976687 |
| 61 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.18703735 |
| 62 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.18330915 |
| 63 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.17357576 |
| 64 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.17165242 |
| 65 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.16739579 |
| 66 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.16389391 |
| 67 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.14959765 |
| 68 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.14701815 |
| 69 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14331582 |
| 70 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.13882841 |
| 71 | SPI1_23127762_ChIP-Seq_K562_Human | 1.13065516 |
| 72 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.13039189 |
| 73 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11976161 |
| 74 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11339684 |
| 75 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11018671 |
| 76 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.10011318 |
| 77 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.09401613 |
| 78 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.09016183 |
| 79 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07955588 |
| 80 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06858221 |
| 81 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.06748346 |
| 82 | P300_27268052_Chip-Seq_Bcells_Human | 1.06145402 |
| 83 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.05777100 |
| 84 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.04248011 |
| 85 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.04159111 |
| 86 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.03918329 |
| 87 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.03910603 |
| 88 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03899331 |
| 89 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.03169558 |
| 90 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.01729195 |
| 91 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.01401379 |
| 92 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.00861208 |
| 93 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.00733519 |
| 94 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98913653 |
| 95 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.97737135 |
| 96 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96794766 |
| 97 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.94416108 |
| 98 | * SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.94134409 |
| 99 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.93773760 |
| 100 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.91263051 |
| 101 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.91019615 |
| 102 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88393516 |
| 103 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.87706516 |
| 104 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.84843250 |
| 105 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.84761397 |
| 106 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.84732940 |
| 107 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.84378903 |
| 108 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.84144959 |
| 109 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.84117364 |
| 110 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.83650236 |
| 111 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83628243 |
| 112 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.82883343 |
| 113 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.82575958 |
| 114 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82136865 |
| 115 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.81546437 |
| 116 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.80018874 |
| 117 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.78881688 |
| 118 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.78548312 |
| 119 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.76720268 |
| 120 | SA1_27219007_Chip-Seq_Bcells_Human | 0.74291327 |
| 121 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.74078515 |
| 122 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.73171990 |
| 123 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.72789150 |
| 124 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.69496509 |
| 125 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.69299092 |
| 126 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.68908574 |
| 127 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.68887492 |
| 128 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.68316398 |
| 129 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.67282930 |
| 130 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67058349 |
| 131 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.66013358 |
| 132 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.65228609 |
| 133 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.64790445 |
| 134 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.63053037 |
| 135 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.62080430 |
| 136 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.61972645 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 6.37019025 |
| 2 | MP0005671_abnormal_response_to | 5.56966537 |
| 3 | MP0009333_abnormal_splenocyte_physiolog | 3.20986381 |
| 4 | MP0000685_abnormal_immune_system | 3.08830265 |
| 5 | MP0001800_abnormal_humoral_immune | 3.07046836 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.85090052 |
| 7 | MP0002420_abnormal_adaptive_immunity | 2.81607545 |
| 8 | MP0001819_abnormal_immune_cell | 2.76870504 |
| 9 | * MP0002398_abnormal_bone_marrow | 2.76642289 |
| 10 | MP0002166_altered_tumor_susceptibility | 2.72938297 |
| 11 | MP0000703_abnormal_thymus_morphology | 2.72005276 |
| 12 | MP0001790_abnormal_immune_system | 2.70990321 |
| 13 | MP0005387_immune_system_phenotype | 2.70990321 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.67393018 |
| 15 | MP0002723_abnormal_immune_serum | 2.65871874 |
| 16 | MP0009785_altered_susceptibility_to | 2.64897655 |
| 17 | MP0001873_stomach_inflammation | 2.64703809 |
| 18 | MP0006082_CNS_inflammation | 2.42621061 |
| 19 | * MP0000716_abnormal_immune_system | 2.35620322 |
| 20 | MP0002452_abnormal_antigen_presenting | 2.33173859 |
| 21 | MP0002405_respiratory_system_inflammati | 2.30983784 |
| 22 | MP0002822_catalepsy | 2.27297527 |
| 23 | MP0002006_tumorigenesis | 2.25951812 |
| 24 | MP0005025_abnormal_response_to | 2.23784672 |
| 25 | MP0002722_abnormal_immune_system | 2.23273464 |
| 26 | MP0000689_abnormal_spleen_morphology | 2.11706428 |
| 27 | MP0004381_abnormal_hair_follicle | 2.09556814 |
| 28 | MP0003880_abnormal_central_pattern | 2.03149250 |
| 29 | MP0003191_abnormal_cellular_cholesterol | 1.99763103 |
| 30 | MP0003866_abnormal_defecation | 1.94858834 |
| 31 | * MP0002429_abnormal_blood_cell | 1.85287935 |
| 32 | MP0001533_abnormal_skeleton_physiology | 1.82410251 |
| 33 | MP0004859_abnormal_synaptic_plasticity | 1.80073910 |
| 34 | MP0002396_abnormal_hematopoietic_system | 1.80006948 |
| 35 | MP0005451_abnormal_body_composition | 1.74601440 |
| 36 | MP0004510_myositis | 1.71564050 |
| 37 | MP0005360_urolithiasis | 1.69960920 |
| 38 | MP0002933_joint_inflammation | 1.66905012 |
| 39 | MP0010155_abnormal_intestine_physiology | 1.63283437 |
| 40 | MP0002138_abnormal_hepatobiliary_system | 1.61593205 |
| 41 | MP0002009_preneoplasia | 1.51900544 |
| 42 | MP0000858_altered_metastatic_potential | 1.51426547 |
| 43 | MP0005075_abnormal_melanosome_morpholog | 1.49283552 |
| 44 | MP0003436_decreased_susceptibility_to | 1.46690655 |
| 45 | MP0003172_abnormal_lysosome_physiology | 1.42075650 |
| 46 | MP0002148_abnormal_hypersensitivity_rea | 1.41440762 |
| 47 | MP0002139_abnormal_hepatobiliary_system | 1.40929927 |
| 48 | MP0009840_abnormal_foam_cell | 1.38752657 |
| 49 | MP0004947_skin_inflammation | 1.37445970 |
| 50 | MP0003724_increased_susceptibility_to | 1.37048916 |
| 51 | MP0005423_abnormal_somatic_nervous | 1.36802531 |
| 52 | MP0002419_abnormal_innate_immunity | 1.34040286 |
| 53 | MP0003787_abnormal_imprinting | 1.33199982 |
| 54 | MP0008569_lethality_at_weaning | 1.31884146 |
| 55 | MP0003635_abnormal_synaptic_transmissio | 1.31306798 |
| 56 | MP0008260_abnormal_autophagy | 1.30902814 |
| 57 | MP0001845_abnormal_inflammatory_respons | 1.30012967 |
| 58 | MP0009745_abnormal_behavioral_response | 1.25929161 |
| 59 | MP0005310_abnormal_salivary_gland | 1.24988412 |
| 60 | MP0002132_abnormal_respiratory_system | 1.24645739 |
| 61 | MP0005058_abnormal_lysosome_morphology | 1.24438832 |
| 62 | MP0009278_abnormal_bone_marrow | 1.23639303 |
| 63 | MP0009764_decreased_sensitivity_to | 1.16053900 |
| 64 | MP0005464_abnormal_platelet_physiology | 1.15948245 |
| 65 | MP0001501_abnormal_sleep_pattern | 1.14414604 |
| 66 | MP0005365_abnormal_bile_salt | 1.11728073 |
| 67 | MP0003045_fibrosis | 1.11407216 |
| 68 | MP0003448_altered_tumor_morphology | 1.10906209 |
| 69 | MP0003183_abnormal_peptide_metabolism | 1.06376068 |
| 70 | MP0003806_abnormal_nucleotide_metabolis | 1.04322824 |
| 71 | MP0000465_gastrointestinal_hemorrhage | 1.03083190 |
| 72 | MP0001851_eye_inflammation | 1.01271818 |
| 73 | MP0002277_abnormal_respiratory_mucosa | 1.00764228 |
| 74 | MP0002572_abnormal_emotion/affect_behav | 1.00625338 |
| 75 | MP0003300_gastrointestinal_ulcer | 1.00454626 |
| 76 | MP0002064_seizures | 0.99888488 |
| 77 | MP0003252_abnormal_bile_duct | 0.96453495 |
| 78 | MP0005085_abnormal_gallbladder_physiolo | 0.93619989 |
| 79 | MP0002063_abnormal_learning/memory/cond | 0.93285147 |
| 80 | MP0002735_abnormal_chemical_nociception | 0.89941421 |
| 81 | MP0004130_abnormal_muscle_cell | 0.86681521 |
| 82 | MP0009763_increased_sensitivity_to | 0.86659456 |
| 83 | MP0001853_heart_inflammation | 0.85710249 |
| 84 | MP0001348_abnormal_lacrimal_gland | 0.81501579 |
| 85 | MP0001986_abnormal_taste_sensitivity | 0.81333216 |
| 86 | MP0004883_abnormal_blood_vessel | 0.80867926 |
| 87 | MP0010329_abnormal_lipoprotein_level | 0.78760000 |
| 88 | MP0000609_abnormal_liver_physiology | 0.78737892 |
| 89 | MP0000604_amyloidosis | 0.78324041 |
| 90 | MP0001502_abnormal_circadian_rhythm | 0.78061692 |
| 91 | MP0001968_abnormal_touch/_nociception | 0.75471906 |
| 92 | MP0002019_abnormal_tumor_incidence | 0.74042383 |
| 93 | MP0001984_abnormal_olfaction | 0.74025679 |
| 94 | MP0008961_abnormal_basal_metabolism | 0.72803657 |
| 95 | MP0003075_altered_response_to | 0.72749916 |
| 96 | MP0002272_abnormal_nervous_system | 0.71590686 |
| 97 | MP0008469_abnormal_protein_level | 0.71478680 |
| 98 | MP0008872_abnormal_physiological_respon | 0.71339780 |
| 99 | MP0008874_decreased_physiological_sensi | 0.71287222 |
| 100 | MP0004808_abnormal_hematopoietic_stem | 0.70556807 |
| 101 | MP0005390_skeleton_phenotype | 0.70458405 |
| 102 | MP0005166_decreased_susceptibility_to | 0.68821742 |
| 103 | MP0001529_abnormal_vocalization | 0.68299015 |
| 104 | MP0002638_abnormal_pupillary_reflex | 0.66746516 |
| 105 | MP0002163_abnormal_gland_morphology | 0.66664357 |
| 106 | MP0003690_abnormal_glial_cell | 0.64855071 |
| 107 | MP0000490_abnormal_crypts_of | 0.64094374 |
| 108 | MP0004185_abnormal_adipocyte_glucose | 0.63049508 |
| 109 | MP0006072_abnormal_retinal_apoptosis | 0.62640744 |
| 110 | MP0003329_amyloid_beta_deposits | 0.62342465 |
| 111 | MP0001905_abnormal_dopamine_level | 0.62276350 |
| 112 | MP0009643_abnormal_urine_homeostasis | 0.62265819 |
| 113 | MP0005377_hearing/vestibular/ear_phenot | 0.61983926 |
| 114 | MP0003878_abnormal_ear_physiology | 0.61983926 |
| 115 | MP0005645_abnormal_hypothalamus_physiol | 0.61800498 |
| 116 | MP0002998_abnormal_bone_remodeling | 0.61589221 |
| 117 | MP0005397_hematopoietic_system_phenotyp | 0.60180501 |
| 118 | MP0001545_abnormal_hematopoietic_system | 0.60180501 |
| 119 | MP0005083_abnormal_biliary_tract | 0.60136783 |
| 120 | MP0003303_peritoneal_inflammation | 0.60082289 |
| 121 | MP0002736_abnormal_nociception_after | 0.59407222 |
| 122 | MP0001970_abnormal_pain_threshold | 0.59287508 |
| 123 | MP0008877_abnormal_DNA_methylation | 0.58824913 |
| 124 | MP0002557_abnormal_social/conspecific_i | 0.58458184 |
| 125 | MP0001764_abnormal_homeostasis | 0.57991941 |
| 126 | MP0005319_abnormal_enzyme/_coenzyme | 0.57605203 |
| 127 | MP0005381_digestive/alimentary_phenotyp | 0.57338941 |
| 128 | MP0009642_abnormal_blood_homeostasis | 0.57281085 |
| 129 | MP0000249_abnormal_blood_vessel | 0.56726283 |
| 130 | MP0008875_abnormal_xenobiotic_pharmacok | 0.55307668 |
| 131 | MP0002184_abnormal_innervation | 0.53307623 |
| 132 | MP0005499_abnormal_olfactory_system | 0.53211675 |
| 133 | MP0005394_taste/olfaction_phenotype | 0.53211675 |
| 134 | MP0002089_abnormal_postnatal_growth/wei | 0.52692529 |
| 135 | MP0009765_abnormal_xenobiotic_induced | 0.52560399 |
| 136 | MP0002693_abnormal_pancreas_physiology | 0.50862482 |
| 137 | MP0006276_abnormal_autonomic_nervous | 0.49838825 |
| 138 | MP0002083_premature_death | 0.49388479 |
| 139 | MP0001486_abnormal_startle_reflex | 0.48263741 |
| 140 | MP0004924_abnormal_behavior | 0.47501340 |
| 141 | MP0005386_behavior/neurological_phenoty | 0.47501340 |
| 142 | MP0002733_abnormal_thermal_nociception | 0.45657854 |
| 143 | MP0001663_abnormal_digestive_system | 0.44921519 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 8.58892648 |
| 2 | Abnormality of T cell number (HP:0011839) | 8.27935032 |
| 3 | Severe combined immunodeficiency (HP:0004430) | 6.22675831 |
| 4 | Abnormality of T cells (HP:0002843) | 5.77158236 |
| 5 | Combined immunodeficiency (HP:0005387) | 5.77048983 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.35338107 |
| 7 | Recurrent bronchitis (HP:0002837) | 5.14120197 |
| 8 | Stomatitis (HP:0010280) | 4.99210932 |
| 9 | IgG deficiency (HP:0004315) | 4.73710034 |
| 10 | Increased IgM level (HP:0003496) | 4.65576588 |
| 11 | Autoimmune hemolytic anemia (HP:0001890) | 4.59982024 |
| 12 | Abnormality of macrophages (HP:0004311) | 4.44890381 |
| 13 | Recurrent bacterial skin infections (HP:0005406) | 4.30001603 |
| 14 | Panhypogammaglobulinemia (HP:0003139) | 4.29328124 |
| 15 | IgM deficiency (HP:0002850) | 4.20690202 |
| 16 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.19001635 |
| 17 | Thyroiditis (HP:0100646) | 4.05290010 |
| 18 | Nasal polyposis (HP:0100582) | 4.02062649 |
| 19 | Chronic otitis media (HP:0000389) | 3.90647739 |
| 20 | Abnormality of eosinophils (HP:0001879) | 3.86620346 |
| 21 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.84921276 |
| 22 | Recurrent cutaneous fungal infections (HP:0011370) | 3.83386438 |
| 23 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.83386438 |
| 24 | Myositis (HP:0100614) | 3.78564087 |
| 25 | Recurrent fungal infections (HP:0002841) | 3.73094472 |
| 26 | Lymphopenia (HP:0001888) | 3.65688810 |
| 27 | Joint swelling (HP:0001386) | 3.65631205 |
| 28 | Recurrent viral infections (HP:0004429) | 3.58620796 |
| 29 | Abnormality of B cell number (HP:0010975) | 3.52905274 |
| 30 | B lymphocytopenia (HP:0010976) | 3.52905274 |
| 31 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.52564115 |
| 32 | Chronic diarrhea (HP:0002028) | 3.43481853 |
| 33 | Abnormality of binocular vision (HP:0011514) | 3.40828057 |
| 34 | Diplopia (HP:0000651) | 3.40828057 |
| 35 | Abnormality of the fingertips (HP:0001211) | 3.17268350 |
| 36 | Hypochromic anemia (HP:0001931) | 3.13006743 |
| 37 | Abnormality of the nasal mucosa (HP:0000433) | 3.12443183 |
| 38 | Spontaneous hematomas (HP:0007420) | 3.08792554 |
| 39 | Meningitis (HP:0001287) | 3.08336794 |
| 40 | Abnormality of T cell physiology (HP:0011840) | 3.04612147 |
| 41 | Leukocytosis (HP:0001974) | 3.00545122 |
| 42 | Encephalitis (HP:0002383) | 2.95594312 |
| 43 | Cellulitis (HP:0100658) | 2.91225591 |
| 44 | Recurrent sinusitis (HP:0011108) | 2.88231722 |
| 45 | Chronic sinusitis (HP:0011109) | 2.87522134 |
| 46 | Hypoplasia of the thymus (HP:0000778) | 2.86336185 |
| 47 | Purpura (HP:0000979) | 2.82898554 |
| 48 | Optic neuritis (HP:0100653) | 2.82563809 |
| 49 | Retrobulbar optic neuritis (HP:0100654) | 2.82563809 |
| 50 | Hypergammaglobulinemia (HP:0010702) | 2.81874636 |
| 51 | Hypochromic microcytic anemia (HP:0004840) | 2.81249589 |
| 52 | Agammaglobulinemia (HP:0004432) | 2.81013883 |
| 53 | Deep venous thrombosis (HP:0002625) | 2.80842526 |
| 54 | Gastrointestinal infarctions (HP:0005244) | 2.80815613 |
| 55 | Mediastinal lymphadenopathy (HP:0100721) | 2.80738013 |
| 56 | Vasculitis (HP:0002633) | 2.73483675 |
| 57 | Eosinophilia (HP:0001880) | 2.70559651 |
| 58 | Bronchitis (HP:0012387) | 2.70011267 |
| 59 | Hemoptysis (HP:0002105) | 2.69978145 |
| 60 | Pustule (HP:0200039) | 2.69694126 |
| 61 | Gastrointestinal inflammation (HP:0004386) | 2.67459315 |
| 62 | Urticaria (HP:0001025) | 2.67165389 |
| 63 | Pulmonary infiltrates (HP:0002113) | 2.66820967 |
| 64 | Colitis (HP:0002583) | 2.64848581 |
| 65 | Inflammation of the large intestine (HP:0002037) | 2.64359280 |
| 66 | Lymphoma (HP:0002665) | 2.64186928 |
| 67 | Gingivitis (HP:0000230) | 2.59176800 |
| 68 | Joint hemorrhage (HP:0005261) | 2.55086022 |
| 69 | Basal cell carcinoma (HP:0002671) | 2.53597561 |
| 70 | Hyperlipoproteinemia (HP:0010980) | 2.47998366 |
| 71 | Obstructive lung disease (HP:0006536) | 2.47819035 |
| 72 | Chronic obstructive pulmonary disease (HP:0006510) | 2.47819035 |
| 73 | Petechiae (HP:0000967) | 2.44388939 |
| 74 | Sepsis (HP:0100806) | 2.42977223 |
| 75 | Gingival bleeding (HP:0000225) | 2.42230202 |
| 76 | Systemic lupus erythematosus (HP:0002725) | 2.41275415 |
| 77 | Keratoconjunctivitis sicca (HP:0001097) | 2.38577757 |
| 78 | Abnormality of the prostate (HP:0008775) | 2.32269875 |
| 79 | Granulocytopenia (HP:0001913) | 2.31795626 |
| 80 | IgA deficiency (HP:0002720) | 2.30577135 |
| 81 | Aplastic anemia (HP:0001915) | 2.29752315 |
| 82 | Slow saccadic eye movements (HP:0000514) | 2.29739063 |
| 83 | Microcytic anemia (HP:0001935) | 2.28312475 |
| 84 | Recurrent otitis media (HP:0000403) | 2.26614623 |
| 85 | Hemorrhage of the eye (HP:0011885) | 2.25890835 |
| 86 | Verrucae (HP:0200043) | 2.24959448 |
| 87 | Papilloma (HP:0012740) | 2.24959448 |
| 88 | Abnormal hair whorl (HP:0010721) | 2.18201136 |
| 89 | Increased IgE level (HP:0003212) | 2.15372067 |
| 90 | Keratoconjunctivitis (HP:0001096) | 2.14184996 |
| 91 | Eczematoid dermatitis (HP:0000976) | 2.13819960 |
| 92 | Increased serum ferritin (HP:0003281) | 2.12710396 |
| 93 | Anorexia (HP:0002039) | 2.12383201 |
| 94 | Episodic fever (HP:0001954) | 2.10232316 |
| 95 | Acute hepatic failure (HP:0006554) | 2.09792170 |
| 96 | Orchitis (HP:0100796) | 2.07527038 |
| 97 | Focal motor seizures (HP:0011153) | 2.07275287 |
| 98 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.04654051 |
| 99 | Abnormality of the pleura (HP:0002103) | 2.04404920 |
| 100 | Gastrointestinal stroma tumor (HP:0100723) | 2.03933590 |
| 101 | Gangrene (HP:0100758) | 2.00541798 |
| 102 | Hemiplegia (HP:0002301) | 1.99499469 |
| 103 | Ureteral stenosis (HP:0000071) | 1.98512108 |
| 104 | Recurrent pneumonia (HP:0006532) | 1.97793008 |
| 105 | Acne (HP:0001061) | 1.96273555 |
| 106 | Autoimmune thrombocytopenia (HP:0001973) | 1.93766181 |
| 107 | Asplenia (HP:0001746) | 1.93512189 |
| 108 | Amyotrophic lateral sclerosis (HP:0007354) | 1.89737374 |
| 109 | Skin ulcer (HP:0200042) | 1.88244863 |
| 110 | Chest pain (HP:0100749) | 1.87985937 |
| 111 | Recurrent skin infections (HP:0001581) | 1.87723758 |
| 112 | Pulmonary embolism (HP:0002204) | 1.87502537 |
| 113 | Cheilitis (HP:0100825) | 1.87319471 |
| 114 | Skin rash (HP:0000988) | 1.86411058 |
| 115 | J-shaped sella turcica (HP:0002680) | 1.84469575 |
| 116 | Prolonged partial thromboplastin time (HP:0003645) | 1.84087535 |
| 117 | Febrile seizures (HP:0002373) | 1.82979559 |
| 118 | Prolonged bleeding time (HP:0003010) | 1.81980666 |
| 119 | Abnormality of oral frenula (HP:0000190) | 1.81563244 |
| 120 | Epistaxis (HP:0000421) | 1.76396363 |
| 121 | Hypoproteinemia (HP:0003075) | 1.75227031 |
| 122 | Recurrent abscess formation (HP:0002722) | 1.74762112 |
| 123 | Abnormality of DNA repair (HP:0003254) | 1.71345648 |
| 124 | Arterial thrombosis (HP:0004420) | 1.68604836 |
| 125 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.68327631 |
| 126 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.67612264 |
| 127 | Hepatitis (HP:0012115) | 1.67355707 |
| 128 | Bronchiectasis (HP:0002110) | 1.66101784 |
| 129 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.63970484 |
| 130 | Thrombocytosis (HP:0001894) | 1.62329728 |
| 131 | Progressive inability to walk (HP:0002505) | 1.62149675 |
| 132 | Ureteral obstruction (HP:0006000) | 1.60527873 |
| 133 | Poikiloderma (HP:0001029) | 1.60322175 |
| 134 | Seborrheic dermatitis (HP:0001051) | 1.57556235 |
| 135 | Abnormality of secondary sexual hair (HP:0009888) | 1.57043962 |
| 136 | Abnormality of the axillary hair (HP:0100134) | 1.57043962 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 6.90947544 |
| 2 | MAP4K1 | 5.65695787 |
| 3 | ITK | 3.61144570 |
| 4 | ZAP70 | 3.27361915 |
| 5 | ERN1 | 3.00949493 |
| 6 | GRK6 | 2.68966314 |
| 7 | JAK3 | 2.55347853 |
| 8 | IKBKE | 2.42015935 |
| 9 | SIK2 | 2.27504160 |
| 10 | MAP3K11 | 2.26225052 |
| 11 | FGFR4 | 2.24991162 |
| 12 | TYK2 | 2.19853444 |
| 13 | JAK1 | 2.13266776 |
| 14 | MAP3K12 | 2.06115377 |
| 15 | TRIB3 | 1.94431481 |
| 16 | RIPK1 | 1.92242212 |
| 17 | TNK2 | 1.88974330 |
| 18 | CLK1 | 1.87658326 |
| 19 | * LCK | 1.87457442 |
| 20 | TAOK3 | 1.84316157 |
| 21 | SIK1 | 1.74593907 |
| 22 | MST4 | 1.73424324 |
| 23 | NLK | 1.69598631 |
| 24 | SYK | 1.66633841 |
| 25 | MAP2K3 | 1.59602205 |
| 26 | FGFR3 | 1.58731760 |
| 27 | CSK | 1.51972808 |
| 28 | SIK3 | 1.47766511 |
| 29 | PRKCH | 1.43658615 |
| 30 | TBK1 | 1.43540050 |
| 31 | TEC | 1.42765428 |
| 32 | STK10 | 1.42264381 |
| 33 | MAP3K14 | 1.41732144 |
| 34 | NME2 | 1.37087567 |
| 35 | BLK | 1.36054323 |
| 36 | HCK | 1.35192205 |
| 37 | CAMKK1 | 1.33405879 |
| 38 | EPHB1 | 1.29925553 |
| 39 | BTK | 1.29701955 |
| 40 | FES | 1.28354285 |
| 41 | TAOK1 | 1.24348324 |
| 42 | PRKCQ | 1.23599974 |
| 43 | SMG1 | 1.19519563 |
| 44 | KDR | 1.19015184 |
| 45 | TESK1 | 1.18299112 |
| 46 | PASK | 1.15212821 |
| 47 | MAP3K13 | 1.13450996 |
| 48 | IRAK4 | 1.12017399 |
| 49 | CSF1R | 1.10820279 |
| 50 | MAP3K3 | 1.07172279 |
| 51 | TAOK2 | 1.03452960 |
| 52 | SCYL2 | 1.00368412 |
| 53 | BRD4 | 0.98421273 |
| 54 | MARK3 | 0.89047092 |
| 55 | MAP3K10 | 0.85347258 |
| 56 | MAP3K1 | 0.85011903 |
| 57 | NTRK2 | 0.84834932 |
| 58 | EPHA4 | 0.84404304 |
| 59 | CAMKK2 | 0.82994993 |
| 60 | MAP3K7 | 0.82577562 |
| 61 | LYN | 0.82467054 |
| 62 | PRKD2 | 0.80548623 |
| 63 | KIT | 0.78901551 |
| 64 | FGR | 0.78207442 |
| 65 | FYN | 0.75851030 |
| 66 | PTK6 | 0.75242637 |
| 67 | TNIK | 0.71024861 |
| 68 | MARK2 | 0.70356913 |
| 69 | GRK7 | 0.68678070 |
| 70 | PRPF4B | 0.66265197 |
| 71 | TYRO3 | 0.65819782 |
| 72 | PDPK1 | 0.64781409 |
| 73 | MAP2K6 | 0.61511720 |
| 74 | DAPK1 | 0.60139989 |
| 75 | EEF2K | 0.59619187 |
| 76 | DYRK1A | 0.56993544 |
| 77 | JAK2 | 0.55574159 |
| 78 | TESK2 | 0.52756979 |
| 79 | HIPK2 | 0.51712035 |
| 80 | IKBKB | 0.50855560 |
| 81 | DYRK1B | 0.50005519 |
| 82 | CDC42BPA | 0.49918855 |
| 83 | ADRBK2 | 0.49402137 |
| 84 | IRAK3 | 0.45938552 |
| 85 | RPS6KC1 | 0.45612840 |
| 86 | RPS6KL1 | 0.45612840 |
| 87 | NTRK3 | 0.45585546 |
| 88 | MUSK | 0.45307913 |
| 89 | INSR | 0.45207664 |
| 90 | BCKDK | 0.42777778 |
| 91 | LRRK2 | 0.42667573 |
| 92 | MAP2K2 | 0.42180262 |
| 93 | PDK1 | 0.41773543 |
| 94 | MAPK12 | 0.40628873 |
| 95 | TSSK6 | 0.40542224 |
| 96 | STK38 | 0.38224544 |
| 97 | MAPK13 | 0.38196694 |
| 98 | RPS6KA6 | 0.37705137 |
| 99 | STK11 | 0.37465244 |
| 100 | MAPKAPK2 | 0.35765802 |
| 101 | MYLK | 0.34689311 |
| 102 | BMX | 0.33712773 |
| 103 | IGF1R | 0.32795874 |
| 104 | CDK4 | 0.32656766 |
| 105 | DMPK | 0.31989482 |
| 106 | UHMK1 | 0.31808009 |
| 107 | PIM1 | 0.30416098 |
| 108 | MAPK7 | 0.29548140 |
| 109 | KSR2 | 0.29162495 |
| 110 | MELK | 0.28584717 |
| 111 | CDK5 | 0.28344911 |
| 112 | PRKCB | 0.28274202 |
| 113 | TLK1 | 0.28003188 |
| 114 | CDK19 | 0.27779809 |
| 115 | PKN2 | 0.27195077 |
| 116 | ICK | 0.25676083 |
| 117 | MAPK9 | 0.25558907 |
| 118 | MAP2K7 | 0.24827632 |
| 119 | CHUK | 0.24057748 |
| 120 | SGK3 | 0.24002512 |
| 121 | PRKCI | 0.23486244 |
| 122 | FGFR1 | 0.23170746 |
| 123 | CAMK2B | 0.22997294 |
| 124 | MAPK11 | 0.22478545 |
| 125 | CDK3 | 0.22246077 |
| 126 | SGK2 | 0.21968142 |
| 127 | CSNK1A1L | 0.20614102 |
| 128 | IRAK2 | 0.20520437 |
| 129 | MAPK4 | 0.20484325 |
| 130 | RIPK4 | 0.19967108 |
| 131 | SRC | 0.19361695 |
| 132 | BMPR2 | 0.17996775 |
| 133 | MAPK8 | 0.16706118 |
| 134 | PRKCD | 0.16414902 |
| 135 | CDK11A | 0.16409384 |
| 136 | MAPK3 | 0.16378874 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.88179148 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.74342132 |
| 3 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.91604908 |
| 4 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.68323120 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 3.39114787 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.09991806 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.62466239 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.50099071 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.43373226 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.38479035 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.28211037 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.97620603 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.81067948 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 1.71772966 |
| 15 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.70736048 |
| 16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.65666785 |
| 17 | Ribosome_Homo sapiens_hsa03010 | 1.62783116 |
| 18 | Nicotine addiction_Homo sapiens_hsa05033 | 1.58198852 |
| 19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.56462681 |
| 20 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.39564839 |
| 21 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.38959568 |
| 22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.30598962 |
| 23 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.27190794 |
| 24 | Leishmaniasis_Homo sapiens_hsa05140 | 1.20531284 |
| 25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.18950026 |
| 26 | Asthma_Homo sapiens_hsa05310 | 1.17261009 |
| 27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.15165548 |
| 28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.11658286 |
| 29 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.10080339 |
| 30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.07095376 |
| 31 | Long-term potentiation_Homo sapiens_hsa04720 | 1.05886316 |
| 32 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.04135673 |
| 33 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.02110025 |
| 34 | Pertussis_Homo sapiens_hsa05133 | 1.00075124 |
| 35 | Morphine addiction_Homo sapiens_hsa05032 | 0.98201478 |
| 36 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.93323438 |
| 37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.91386195 |
| 38 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.89091290 |
| 39 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.85066398 |
| 40 | Olfactory transduction_Homo sapiens_hsa04740 | 0.84420077 |
| 41 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.80568834 |
| 42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.80199243 |
| 43 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.79634366 |
| 44 | HTLV-I infection_Homo sapiens_hsa05166 | 0.78045532 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 0.77966391 |
| 46 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.72723552 |
| 47 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.68534847 |
| 48 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.67734820 |
| 49 | Circadian entrainment_Homo sapiens_hsa04713 | 0.66491130 |
| 50 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.64293688 |
| 51 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64059792 |
| 52 | Shigellosis_Homo sapiens_hsa05131 | 0.63327246 |
| 53 | Colorectal cancer_Homo sapiens_hsa05210 | 0.62768049 |
| 54 | Spliceosome_Homo sapiens_hsa03040 | 0.61904062 |
| 55 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.61666198 |
| 56 | Insulin resistance_Homo sapiens_hsa04931 | 0.61528553 |
| 57 | Influenza A_Homo sapiens_hsa05164 | 0.61246210 |
| 58 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.61012286 |
| 59 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.59553690 |
| 60 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.59540797 |
| 61 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.59430833 |
| 62 | Legionellosis_Homo sapiens_hsa05134 | 0.59240912 |
| 63 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.58771139 |
| 64 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.56891341 |
| 65 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56878755 |
| 66 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56816686 |
| 67 | GABAergic synapse_Homo sapiens_hsa04727 | 0.56230436 |
| 68 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55241296 |
| 69 | Phagosome_Homo sapiens_hsa04145 | 0.54915446 |
| 70 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.54814308 |
| 71 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.54343754 |
| 72 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.54216490 |
| 73 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.53460698 |
| 74 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.53348555 |
| 75 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.52954982 |
| 76 | Platelet activation_Homo sapiens_hsa04611 | 0.50652811 |
| 77 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.50214464 |
| 78 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.50099155 |
| 79 | Salivary secretion_Homo sapiens_hsa04970 | 0.49850565 |
| 80 | Sulfur relay system_Homo sapiens_hsa04122 | 0.49216166 |
| 81 | Prion diseases_Homo sapiens_hsa05020 | 0.49093728 |
| 82 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.48855309 |
| 83 | ABC transporters_Homo sapiens_hsa02010 | 0.48778172 |
| 84 | Taste transduction_Homo sapiens_hsa04742 | 0.48766925 |
| 85 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.48248021 |
| 86 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.47709442 |
| 87 | Renin secretion_Homo sapiens_hsa04924 | 0.47524425 |
| 88 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.47070897 |
| 89 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.46973703 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46641738 |
| 91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.46441345 |
| 92 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.45933070 |
| 93 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45603644 |
| 94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.45493393 |
| 95 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.44847758 |
| 96 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.44831298 |
| 97 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.44656421 |
| 98 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.44496330 |
| 99 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.42744581 |
| 100 | Cocaine addiction_Homo sapiens_hsa05030 | 0.41963229 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41782384 |
| 102 | Apoptosis_Homo sapiens_hsa04210 | 0.41246299 |
| 103 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.41231283 |
| 104 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.40932399 |
| 105 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.40708390 |
| 106 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.40679855 |
| 107 | Endocytosis_Homo sapiens_hsa04144 | 0.39793731 |
| 108 | Retinol metabolism_Homo sapiens_hsa00830 | 0.39718185 |
| 109 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.39623471 |
| 110 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.38051133 |
| 111 | Hepatitis C_Homo sapiens_hsa05160 | 0.37271561 |
| 112 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.35754922 |
| 113 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.35240058 |
| 114 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.34794694 |
| 115 | Malaria_Homo sapiens_hsa05144 | 0.34721177 |
| 116 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.34706719 |
| 117 | Salmonella infection_Homo sapiens_hsa05132 | 0.34529443 |
| 118 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.34442856 |
| 119 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.33991570 |
| 120 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.32922199 |
| 121 | Tuberculosis_Homo sapiens_hsa05152 | 0.32897448 |
| 122 | Insulin secretion_Homo sapiens_hsa04911 | 0.32242293 |
| 123 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32024686 |
| 124 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.31876469 |
| 125 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.31228190 |
| 126 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.30532954 |
| 127 | RNA degradation_Homo sapiens_hsa03018 | 0.29476147 |
| 128 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.28870800 |
| 129 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.27324659 |
| 130 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.27062076 |
| 131 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.26738566 |
| 132 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.26666430 |
| 133 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.25927070 |
| 134 | Lysosome_Homo sapiens_hsa04142 | 0.25864323 |
| 135 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.25770964 |
| 136 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.25310058 |
| 137 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.24484838 |
| 138 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.24459283 |
| 139 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.23609333 |

